Dr. Wins Fungal Nail Therapy
Kills more than 99.9% of fungi in 1 minute lab tests (fungicidal) lab tests. Conventional topical drugs only inhibit fungal growth (fungistatic). | VIEW LAB REPORT >
Rapidly penetrates nails and skin Applies directly over nails with no need for nail polish removal, or prior cleaning or debridement of nails
Improves appearance of nails in weeks for mild to moderate onychomycosis
Cure or near-cure generally expected in a few months depending on severity of condition
May drastically reduce recurrence rates Recurrence after conventional treatments has been reported to be up to about 40% – mainly attributed to their fungistatic or weak fungicidal properties. Because this formula completely eliminates fungi, recurrence of fungal infection after cure should be zero unless the nail is re-infected.
Simple and easy to use 10ml bottle with a small long-tip applicator for convenient application
Helps promote healthy nail growth May dramatically help shorten the time needed to regrow healthier new nails by up to 100%
Helps quickly relieve pain and inflammation
Superior formula is colorless, odorless, and 99% natural with little or no side effects and no expected drug interaction
Soothes and hydrates with virtually no adverse effects. Contains no alcohol or preservatives, and is non-flammable
Price and performance compares favorably to newest most effective prescription drugs, which cost about $1500 for 10ml, with mean cure rates after 48 weeks of daily application of less than 10% and 20%. In addition to a virtual lack of side effects, Dr. Win’s Fungal Nail Therapy costs about 30 times less those brand name products.
Prophylaxis: Application of 3-4 times a week should be generally adequate for preventing recurrence of fungal infection.
Athlete’s Foot and Ringworm: Due to its extremely potent fungicidal action, this formula should be very effective in treating athlete’s foot and ringworm; probably only a few applications are needed.
- Podiatrist Tested and Approved
All our prices include FREE SHIPPING.